Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (281-290 of 333) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapyC Bokemeyer, A J Gillis, K Pompe, et al.
Journal of Clinical Pathology|May 29, 2009
HER-2/neu analysis in breast cancer bone metastasesJ Zustin, K Boddin, M C Tsourlakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)G Daugaard, I Skoneczna, N Aass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative studyK Oechsle, F Honecker, T Cheng, et al.
Bone Marrow Transplantation|September 4, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with MDSM Christopeit, S Ocheni, T Haferlach, et al.
British Journal of Cancer|July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trialsC Bokemeyer, C Kollmannsberger, S Stenning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumorsC Kollmannsberger, J Beyer, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastasesC Kollmannsberger, C Nichols, M Bamberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H-G Derigs, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Pageof 34

Showing results (281-290 of 333) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapyC Bokemeyer, A J Gillis, K Pompe, et al.
Journal of Clinical Pathology|May 29, 2009
HER-2/neu analysis in breast cancer bone metastasesJ Zustin, K Boddin, M C Tsourlakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)G Daugaard, I Skoneczna, N Aass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative studyK Oechsle, F Honecker, T Cheng, et al.
Bone Marrow Transplantation|September 4, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with MDSM Christopeit, S Ocheni, T Haferlach, et al.
British Journal of Cancer|July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trialsC Bokemeyer, C Kollmannsberger, S Stenning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumorsC Kollmannsberger, J Beyer, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastasesC Kollmannsberger, C Nichols, M Bamberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H-G Derigs, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Pageof 34